Kay-Cee-L

Potassium Chloride, the active ingredient in Kay-Cee-L, is an electrolyte presented as an oral dosage form for oral use. It restores potassium levels in patients with hypokalemia or other potassium deficiencies, supporting normal cellular function, nerve impulse transmission, and muscle contraction.

GNH USA supplies Kay‑Cee‑L as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The product meets EU pharmacopeial standards and is rigorously manufactured under GMP conditions.

Kay-Cee-L, an oral potassium chloride supplement, acts on electrolyte balance to correct low serum potassium.

- Hypokalemia: restores normal serum potassium concentrations in patients with documented low levels. - Potassium deficiency: provides supplemental potassium to prevent or treat deficiency states. - Diuretic‑induced potassium loss: replenishes potassium lost during treatment with loop or thiazide diuretics.

Potassium chloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Abdominal discomfort - Diarrhea

Serious or Rare Side Effects: - Hyperkalemia - Cardiac arrhythmia - Severe allergic reaction - Skin rash

When using Kay-Cee-L, consider the following precautions to ensure safe therapy.

- Serum potassium monitoring: check levels before initiating therapy and periodically during treatment. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Cardiac disease: use cautiously in patients with arrhythmias or heart failure. - Concurrent potassium‑sparing agents: avoid co‑administration to prevent hyperkalemia. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Kay-Cee-L can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors - Angiotensin II receptor blockers (ARBs) - Potassium‑sparing diuretics (e.g., spironolactone)

Moderate Interactions (Monitor Closely): - Digoxin - Non‑steroidal anti‑inflammatory drugs (NSAIDs)